Back
ProShares Short 20+ Yr Treasury Vs. Ascendis Pharma A/S Industry Stock Comparison
Buy
62
TBF
ProShares Short 20+ Yr Treasury
Last Price:
$23.95
Seasonality Move:
-0.66%
Sell
48
ASND
Ascendis Pharma A/S
Last Price:
$209.13
Seasonality Move:
17.83%
Buy
62
ProShares Short 20+ Yr Treasury (TBF)
is a Buy
Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?
-
The current ProShares Short 20+ Yr Treasury [TBF] share price is $23.94. The Score for TBF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
TBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy, Sell or Hold?
-
The current Ascendis Pharma A/S [ASND] share price is $208.98. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBF Stock Price Chart
What is ProShares Short 20+ Yr Treasury's stock price today?
-
The ProShares Short 20+ Yr Treasury share price today is $23.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBF is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma A/S's stock price today?
-
The Ascendis Pharma A/S share price today is $208.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
TBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.33 | Buy |
| Relative Strength Index (14 RSI): | 48.81 | Sell |
| Chaikin Money Flow: | 23185 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.71 - 24.19) | Sell |
| Bollinger Bands (100): | (23.46 - 24.34) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.71 | Buy |
| Relative Strength Index (14 RSI): | 51.55 | Buy |
| Chaikin Money Flow: | -189036 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (202.29 - 212.87) | Buy |
| Bollinger Bands (100): | (194.79 - 209.33) | Buy |
TBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.13 | Sell |
| 20-day SMA: | 24.01 | Sell |
| 50-day SMA: | 23.7 | Buy |
| 200-day SMA: | 24.2 | Sell |
| 8-day EMA: | 18.72 | Buy |
| 20-day EMA: | 10.87 | Buy |
| 50-day EMA: | 5.14 | Buy |
| 200-day EMA: | 1.4 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 206.9 | Buy |
| 20-day SMA: | 207.19 | Buy |
| 50-day SMA: | 205.92 | Buy |
| 200-day SMA: | 183.55 | Buy |
| 8-day EMA: | 208.31 | Buy |
| 20-day EMA: | 207.54 | Buy |
| 50-day EMA: | 205.45 | Buy |
| 200-day EMA: | 185.53 | Buy |
ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.99 per share, and an increase next year of $7.73 per share.
ProShares Short 20+ Yr Treasury Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma A/S Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||